FDA Grants Approval for Amgen’s Blincyto for the Treatment of CD19-Positive Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia. Frank Dolan June 17, 2024
Proposed SEO-optimized title (12 words): BIOSECURE Act Targets Biopharma: Investor Relations Crisis Looms for US Firms Arsenal June 12, 2024
Boehringer Ingelheim Presents Positive Survodutide Phase 2 Results for MASH at EASL Arsenal June 6, 2024
Sarclisa Combo Enhances Survival without Disease Progression in Newly Diagnosed Multiple Myeloma Patients Unfit for Transplant. Frank Dolan June 4, 2024
Phase III Study Results Revealed at ASCO Demonstrate Imfinzi Enhances Survival in Limited-Stage Small Cell Lung Cancer. Frank Dolan June 3, 2024
Comprehending the Influence of the Veradigm Network on Delivering Healthcare Based on Value. Frank Dolan June 1, 2024
Scemblix Demonstrates Enhanced Major Molecular Response in Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Frank Dolan May 31, 2024
SKYRIZI® (Risankizumab) Receives Positive Opinion for Ulcerative Colitis Treatment in Europe Arsenal May 31, 2024
